ISSN: 2278-0238

International Journal of Research and Development in Pharmacy & Life Sciences
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Res Dev Pharm L Sci 2023, Vol 9(2): 154

In - Vitro Drug Interaction between Tulsi and Glimepride

Dr. Yadav Swati*
Department of pharmacists, Vijay collage of pharmacy, Delhi, India
*Corresponding Author : Dr. Yadav Swati, Department of pharmacists, Vijay collage of pharmacy, Delhi, India, Tel: 9753545034, Email: yadavswati1412@gmail.com

Received Date: Apr 01, 2023 / Accepted Date: Apr 27, 2023 / Published Date: Apr 28, 2023

Abstract

The study was designed to determine the interaction of O. sanctum, an herbal drug used in many herbal formulations for hypoglycemic activity with Glimepiride, a sulfonylurea (SU) derivative, widely used in the treatment of type-2 diabetes, in diabetic rats.Whole study was divided into four phases in which hypoglycaemic activity with single doses of O. sanctum and glimeperide was established in single day study and repeated dose treatment of O. sanctum (7 days) followed by a single dose of glimeperide on 8th day was also established. Further the interaction between the two drugs was studied in both single and repeated treatment, i.e., the effect of single and glimeperide repeated doses treatment on O. sanctum. All the results were analysed by one way ANOVA followed by Dunnett’s‘t’ test. Rats were administered with streptozotocin for inducing diabetes and left for 2 weeks to stabilize blood glucose levels. Various doses of O. sanctum (100, 200 and 400 mg/kg) and glimeperide (½ TD, TD and 2 TD) upon single dose treatment of each in different groups of diabetic rats produced a dose dependent decrease in blood glucose levels. The maximum reduction in serum glucose was observed at 6th h in all the groups. Single dose of O. sanctum prolonged the effect of glimepiride from 4th to 6th h without any hypoglycemic convulsions.

Citation: Swati Y (2023) In - Vitro Drug Interaction between Tulsi and Glimepride.Int J Res Dev Pharm L Sci, 9: 154.

Copyright: © 2023 Swati Y. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top